Delivery Order SPE2DB20D6037-SPE2DB22FC9ZW
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract, valued up to $1,543.92, covers the delivery of various medications including branded and generic prescription drugs, over-the-counter products, biologics, and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a range of pharmaceutical products and medical supplies to support military health facilities. The contract has a ceiling value of $1,381.20 and runs through June 28, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a wide range of pharmaceutical products and medical supplies. This order, valued at $2,319.51, is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to $499,999,999. The IDC, under the DLA's SPE2DB program, allows the agency to issue delivery orders for a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract, valued at $1,221.12, is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a ceiling value of up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of pharmaceutical products including prescription drugs, over-the-counter medications, and medical consumables. The contract, valued at up to $1,412.68, supports the recurring medical supply needs of military health facilities worldwide. This award is part of a larger indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the medical needs of military health facilities worldwide. The contract, valued at up to $12,508.75, covers the delivery of various medications and medical consumables, including branded and generic prescription drugs, over-the-counter...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The $2,701.36 contract has a completion date of September 5, 2024 and is part of a larger $499,999,999 indefinite delivery contract (IDC) under the SPE2DB program that runs...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract, valued at up to $2,779.50, has a period of performance through July 28, 2023. This delivery order is part of a larger...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of pharmaceutical products including medications and medical supplies. The delivery order, valued at $2,494.50, has a completion date of September 13, 2022. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999, which allows the DLA to issue...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of various pharmaceutical products and medical supplies. The contract, valued at $31,986.48, has an ultimate completion date of January 25, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. under the SPE2DB program, valued at up to...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB22FC9ZWDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract has a ceiling value of $2,438.40 and an ultimate completion date of April 29, 2022. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. The IDC covers a comprehensive array of pharmaceutical items, from common medications to specialized drugs and medical supplies, to fulfill the diverse medical requirements of the Department of Defense healthcare facilities. This contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 4/28/22 |